02.14.22 -- FDA Releases Draft Guidance On Use Of Real-World Evidence For Drug & Biological Products
02/14/22 Clinical Leader Newsletter
Stay updated with breaking news from Williaml Slone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
02/14/22 Clinical Leader Newsletter
To help shed light on data collection and analysis issues for external controls, this paper examines what constitutes external controls and considers...
Master protocols are created with hypothesis generation intentions to serve as a method to evaluate product utility across a portfolio of indications...
05.24.21 -- Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials This report provides data on 240 service provider encounters with 18 electronic clinical outcome assessment/electronic patient reported outcomes (eCOA/ePRO) systems. eCOA/ePRO providers: Learn how your company performs against competitors. Discover where performance exceeds expectations so you can differentiate your offerings from competitors. For sponsors/CROs: Compare your company’s outsourcing philosophy to that of the broader industry. Evaluate your provider selection pr...
12.21.20 -- Lilly, Care Access Take COVID Trial Directly To Patients Introducing WCG IRB — We’re combining best-in-class capabilities to raise the bar for our industry. Building on our 52-year legacy of expertise and service, our five industry-leading IRBs are now WCG IRB — one unified team protecting human research participants and delivering a seamless review experience. Together at the forefront of research we are reshaping the future of ethical review with our unified experience and revolutionary new submission platform. Empowering research an...